إسرائيل - العربية - Ministry of Health

dexcel pharma technologies ltd - losartan potassium 50 mg - tablets - losartan - hypertension: losardex is indicated for the treatment of hypertension. heart failure: losardex is indicated for the treatment of heart failure (nyha ii and iii) usually in addition to diuretics and/or digitalis if use of an ace inhibitor is not appropriate. switching patients with heart failure who are stable on an ace inhibitor to losardex is not recommended. renal protection in type-2 diabetic patients with proteinuria: losardex is indicated to delay the progression of renal disease as measured by a reduction in the combined incidence of doubling of serum creatinine end stage renal disease (need for dialysis or renal transplantation) or death and to reduce proteinuria. reduction in the risk of cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy. losardex is indicated to reduce the risk of cardiovascular morbidity and mortality as measured by the combined incidence of cardiovascular death stroke and myocardial infarction in hypertensive patients with left ventric

إسرائيل - العربية - Ministry of Health

pfizer pharmaceuticals israel ltd - somatropin recombinant 36 iu/ml - lyophilized powder for injection - somatropin - children: short stature due to inadequate or failed secretion of pituitary growth hormone or turner`s syndrome. short stature in children with renal insufficiency. growth disturbance (height sds<2.5 and parenteral adjusted height sds < -1) in short children born sga (sga - small for gestational age i.e. born small in relation to the length of the fetus development) with a birth witght and/or length < 2 sd who failed to show catch up growth (hv sds < 0 during the last year) by 4 years of age or later. prader willi syndrome for improvement of growth and body composition. adults: for adults who have suffered from growth-hormone deficiency since childhood. for adults who have aquired growth hormone deficiency due to a pituitary pathology causing hypopituitarism.

إسرائيل - العربية - Ministry of Health

roche pharmaceuticals (israel) ltd - isotretinoin 20 mg - capsules - isotretinoin - for the treatment of severe cystic acne that does not respond to other treatment.

إسرائيل - العربية - Ministry of Health

roche pharmaceuticals (israel) ltd - isotretinoin 10 mg - capsules - isotretinoin - for the treatment of severe cystic acne that does not respond to other treatment.

إسرائيل - العربية - Ministry of Health

pfizer pharmaceuticals israel ltd - latanoprost 50 mcg/ml - eye drops - latanoprost - reduction of elevated intraocular pressure as a first line treatment in patients with open-angle galucoma and ocular hypertension.

إسرائيل - العربية - Ministry of Health

bayer israel ltd - cyproterone acetate 2 mg; ethinylestradiol 35 mcg - tablets - cyproterone and estrogen - treatment of moderate to severe acne related to androgen-sensitivity (with or without seborrhoea) and/or hirsutism, in women of reproductive age. for the treatment of acne, diane-35 should only be used after topical therapy or systemic antibiotic treatments have failed.

إسرائيل - العربية - Ministry of Health

abic ltd. - sulphadiazine silver 1 % - cream - silver sulfadiazine - treatment of infected burn wounds, leg ulcers and pressure sores.